A multicentre, observational, retrospective study of alemtuzumab in the treatment of active relapsing–remitting multiple sclerosis
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 03 Nov 2021 New trial record
- 01 Nov 2021 Results published in the Neurological Sciences